president Francisco Sagasti Announcing the signing of an agreement with Chinese pharmaceutical company Sinopharm for the supply of 38 million doses. Vaccine Against COVID-19 In a message to the nation, the president announced that the first million vaccines will arrive in January. Two times required
Read Also
- The Youtuber Squeezie will soon be entering the Grévin museum Nov 25, 2022
- A conference disrupted by far-right activists, Louis Boyard and Carlos Martens Bilongo file a complaint Dec 8, 2022
- Olya Polyakova decided to help the Ukrainians to lose weight Jun 11, 2020
- Why is there no consensus on the contract with Pfizer? Jan 7, 2021
- Naples, Whirlpool starts layoffs for 350 workers. Workers go to Draghi: “We want answers” Jul 15, 2021
- DolarToday: The price of the dollar on Sunday, January 10, 2021 in Venezuela. Jan 10, 2021
- Aston Martin proposes renewal to Vettel | FormulaPassion.it Sep 14, 2021
This is the first agreement the Peruvian state has signed with a pharmaceutical company for the purchase of the vaccine.
Sinopharm vaccine is 79% effective and is “Conditional” for marketing from the Chinese health agency, Sinopharm is the first Chinese pharmaceutical group to report data on the effectiveness of vaccines in their preparations.
United Arab Emirates and Egypt It is the other two countries that have announced they have approved a vaccine made by Sinopharm with the Beijing Institute of Biological Products.
The efficacy rate of Sinopharm’s vaccine is lower than what competitors Pfizer / BioNTech (95%) and Moderna claim (94.1%).
Peru is part of the Phase III clinical trial of the Sinopharm vaccine. Thousands of people volunteer and receive both of these vaccines under the supervision of the Sinopharm. Cayetano Heredia Peruvian University (UPCH) and National University of San Marcos (UNMSM)
